Drugs / C-Tb
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01779102 | Oct 2013 → Sep 2014 | tuberculosis | Statens Serum Institut | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | C-Tb | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01779102 ↗ |
| Modality | Diagnostic / imaging agent | “the diagnostic agents C-Tb and 2 T.U Tuberculin PPD RT 23 SSI” NCT01779102 ↗ |
| Route | Other | “C-Tb is administered by the Mantoux injection technique to each volunteer in the RIGHT or LEFT forearm” NCT01779102 ↗ |